DJIA 17,730.11 0.00 0.00%
NASDAQ 5,009.21 0.00 0.00%
S&P 500 2,076.78 0.00 0.00%
market minute promo

Alnylam Pharmaceuticals (NASDAQ: ALNY)



company name or ticker

Biotech Stock Roundup: Amgen Starts Earnings Season on Strong Note, Setbacks for Ampio & Athersys -

Biotech Stock Roundup: Amgen Starts Earnings Season on Strong Note, Setbacks for Ampio & Athersys - Analyst Blog

Why Alnylam Pharmaceuticals, Inc. Shares Are Soaring Today

Alnylam Pharmaceuticals, Inc. has reported positive phase 2 results for patisiran.

Morning Market Gainers

Benzinga's Top #PreMarket Gainers

CAR-T Therapy Stocks Hit Hard Following AACR Data

It's A Big Weekend For Biotech

New Lifetime High For Alnylam Pharmaceuticals (ALNY)

Big Pharmas' Dirty Little Secret About Cholesterol Lowering Drugs

Alnylam Reports Publication of New Data on Hemophilia Drug - Analyst Blog

Alnylam and Collaborators Publish Pre-clinical Study Results in Nature Medicine on ALN-AT3

See More Articles...